Stefaan Desmedt
TLDR
Stefaan Desmedt is a co-founder of Trince, a Belgian biotech company developing cell therapy manufacturing technology.
Overview
Stefaan Desmedt co-founded Trince alongside Kevin Braeckmans and Philip Mathuis. Trince is a Ghent University spin-off that developed the LumiPore transfection platform for cell-based therapies. The company raised EUR 4M in seed funding from QBIC and Novalis Biotech in 2021.
See also
Co-founderPhilip Mathuis
Co-founderKevin Braeckmans
FounderTrince
LocationGhent
RelatedGhent University
RelatedQBIC